Cancer News and Stories
Our team of experts brings you cancer-related news, features, and survivor stories.
For the latest news about research we conduct and fund, see ACS Research News.
Filtering by:
ImmunotherapyRecent Advances in Lung Cancer Treatment Resulting in Lower Death Rates
Published on: August 17, 2020
According to a new study, death rates from non-small cell lung cancer have fallen sharply in recent years, mostly due to advances in treatment.
FDA Approves First Drug for Cancers with a High Tumor Mutational Burden
Published on: June 18, 2020
The US Food and Drug Administration (FDA) has expanded the approval of the immunotherapy drug pembrolizumab (Keytruda) to include any cancer with a high tumor mutational burden (TMB-H).
FDA Approves Padcev (Enfortumab vedotin-ejfv) for Bladder Cancer
Published on: December 20, 2019
The US Food and Drug Administration (FDA) has approved a new type of drug for certain people with bladder cancer.
2019 in Review: New Cancer Drug Approvals
Published on: December 6, 2019
In 2019, the FDA approved several new drug treatments for different cancer types. Here are the stories that made headlines on cancer.org this year.
FDA Approves Tecentriq (Atezolizumab) for Small Cell Lung Cancer
Published on: March 19, 2019
The US Food and Drug Administration (FDA) has approved the immunotherapy drug Tecentriq (atezolizumab) for the treatment of small cell lung cancer (SCLC).
FDA Approves Immunotherapy for Breast Cancer
Published on: March 11, 2019
The US Food and Drug Administration today approved the first immunotherapy treatment for breast cancer. It approved a combination of Tecentriq (atezolizumab) and Abraxane (nab-paclitaxel) for people with advanced triple negative breast cancer.
2018 in Review: New Cancer Drug Approvals
Published on: December 28, 2018
In 2018, the FDA approved several new drug treatments for different cancer types that American Cancer Society editors believe will make a significant difference.
Study Supports Immunotherapy for Treating Triple-Negative Breast Cancer
Published on: October 30, 2018
A study by an international group of researchers has found for the first time that a combination of immunotherapy and chemotherapy can extend lives of women with triple-negative breast cancer.